Skip to main content

Abnormal Uterine Bleeding

  • Reference work entry
  • First Online:
Female Reproductive Dysfunction

Part of the book series: Endocrinology ((ENDOCR))

  • 708 Accesses

Abstract

Abnormal uterine bleeding (AUB) is a chronic debilitating condition affecting women worldwide with a significant negative impact on their quality of life. Management choices are determined in partnership with an individual woman’s need for uterine and fertility preservation. Although a diverse range of medical and surgical treatment choices are available, a tailored and phenotype-dependent approach to management still remains lacking. AUB, therefore, represents an area of unmet clinical need where future research is needed to optimize information underpinning management choices for women.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Abbott JA. Adenomyosis and abnormal uterine bleeding (AUB-A)-pathogenesis, diagnosis, and management. Best Pract Res Clin Obstet Gynaecol. 2017;40:68–81.

    Article  PubMed  Google Scholar 

  • Abdel-Aleem H, d’Arcangues C, Vogelsong KM, Gaffield ML, Gulmezoglu AM. Treatment of vaginal bleeding irregularities induced by progestin only contraceptives. Cochrane Database Syst Rev. 2013;7:CD003449.

    Google Scholar 

  • Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100–7.

    Article  PubMed  Google Scholar 

  • Borges LM, Scapinelli A, de Baptista Depes D, Lippi UG, Coelho Lopes RG. Findings in patients with postmenstrual spotting with prior cesarean section. J Minim Invasive Gynecol. 2010;17(3):361–4.

    Article  PubMed  Google Scholar 

  • Brohl AS, Li L, Andikyan V, Obican SG, Cioffi A, Hao K, et al. Age-stratified risk of unexpected uterine sarcoma following surgery for presumed benign leiomyoma. Oncologist. 2015;20(4):433–9.

    Article  PubMed  PubMed Central  Google Scholar 

  • Champaneria R, Abedin P, Daniels J, Balogun M, Khan KS. Ultrasound scan and magnetic resonance imaging for the diagnosis of adenomyosis: systematic review comparing test accuracy. Acta Obstet Gynecol Scand. 2010;89(11):1374–84.

    Article  PubMed  Google Scholar 

  • Chen I, Firth B, Hopkins L, Bougie O, Xie RH, Singh S. Clinical characteristics differentiating uterine sarcoma and fibroids. J Soc Laparoendosc Surg. 2018;22(1):e.2017.00066.

    Article  Google Scholar 

  • Chodankar R, Allison J. New horizons in fibroid management. J Curr Obsatet Gynaecol Rep. 2018;7(2):106–15.

    Article  Google Scholar 

  • Chodankar R, Critchley HOD. Biomarkers in abnormal uterine bleeding. Biol Reprod. 2018. https://doi.org/10.1093/biolre/ioy231.

    Article  PubMed Central  Google Scholar 

  • Chodankar R, Critchley HO. Abnormal uterine bleeding (including PALM COEIN classification). Obstet Gynaecol Reprod Med. 2019;29:98.. (in press)

    Article  Google Scholar 

  • Chodankar R, Harpur A, Mahmood T. Heavy menstrual bleeding. Obstet Gynaecol Reprod Med. 2018;28(7):196–202.

    Article  Google Scholar 

  • Critchley HO, Maybin JA. Molecular and cellular causes of abnormal uterine bleeding of endometrial origin. Semin Reprod Med. 2011;29(5):400–9.

    Article  CAS  PubMed  Google Scholar 

  • Daniels JP, Middleton LJ, Champaneria R, Khan KS, Cooper K, Mol BW, et al. Second generation endometrial ablation techniques for heavy menstrual bleeding: network meta-analysis. BMJ. 2012;344:e2564.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • EMA. Esmya: new measures to minimise risk of rare but serious liver injury; 2018. https://www.ema.europa.eu/documents/referral/esmya-article-20-procedure-esmya-new-measures-minimise-risk-rare-serious-liver-injury_en-0.pdf

  • eMC. Esmya 5 mg tablets (ulipristal acetate) electronic Medicines Compendium (eMC); 2018. http://www.medicines.org.uk/emc/medicine/26068

  • Fergusson RJ, Lethaby A, Shepperd S, Farquhar C. Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding. Cochrane Database Syst Rev. 2013;11:CD000329.

    Google Scholar 

  • Fraser IS, Critchley HO, Munro MG, Broder M. Can we achieve international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding? Hum Reprod. 2007a;22(3):635–43.

    Article  PubMed  Google Scholar 

  • Fraser IS, Critchley HO, Munro MG, Broder M. A process designed to lead to international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding. Fertil Steril. 2007b;87(3):466–76.

    Article  PubMed  Google Scholar 

  • Fraser IS, Critchley HO, Broder M, Munro MG. The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding. Semin Reprod Med. 2011;29(5):383–90.

    Article  PubMed  Google Scholar 

  • FSRH. Clinical guidance: problematic bleeding with hormonal contraception: faculty of sexual & reproductive healthcare (FSRH); 2015. https://www.fsrh.org/documents/ceuguidanceproblematicbleedinghormonalcontraception/

  • Garcia L, Isaacson K. Adenomyosis: review of the literature. J Minim Invasive Gynecol. 2011;18(4):428–37.

    Article  PubMed  Google Scholar 

  • Guttinger A, Critchley HO. Endometrial effects of intrauterine levonorgestrel. Contraception. 2007;75(6 Suppl):S93–8.

    Article  CAS  PubMed  Google Scholar 

  • Hoffman MK, Meilstrup JW, Shackelford DP, Kaminski PF. Arteriovenous malformations of the uterus: an uncommon cause of vaginal bleeding. Obstet Gynecol Surv. 1997;52(12):736–40.

    Article  CAS  PubMed  Google Scholar 

  • Jacobson FJ, Enzer N. Uterine myomas and the endometrium; study of the mechanism of bleeding. Obstet Gynecol. 1956;7(2):206–10.

    CAS  PubMed  Google Scholar 

  • Kouides PA, Conard J, Peyvandi F, Lukes A, Kadir R. Hemostasis and menstruation: appropriate investigation for underlying disorders of hemostasis in women with excessive menstrual bleeding. Fertil Steril. 2005;84(5):1345–51.

    Article  PubMed  Google Scholar 

  • Lieng M, Istre O, Sandvik L, Qvigstad E. Prevalence, 1-year regression rate, and clinical significance of asymptomatic endometrial polyps: cross-sectional study. J Minim Invasive Gynecol. 2009;16(4):465–71.

    Article  PubMed  Google Scholar 

  • Lieng M, Istre O, Qvigstad E. Treatment of endometrial polyps: a systematic review. Acta Obstet Gynecol Scand. 2010;89(8):992–1002.

    Article  PubMed  Google Scholar 

  • Liu X, Ding D, Ren Y, Guo SW. Transvaginal Elastosonography as an Imaging Technique for Diagnosing Adenomyosis. Reprod Sci. 2018;25(4):498–514.

    Article  PubMed  Google Scholar 

  • Mansour D. Safer prescribing of therapeutic norethisterone for women at risk of venous thromboembolism. J Fam Plann Reprod Health Care. 2012;38(3):148–9.

    Article  PubMed  Google Scholar 

  • Maybin JA, Critchley HO. Menstrual physiology: implications for endometrial pathology and beyond. Hum Reprod Update. 2015;21(6):748–61.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • MHRA. Esmya (ulipristil acetate) for symptoms of uterine fibroids: restrictions to use and requirement to check liver function before, during and after treatment: medicines and healthcare products regulatory agency (MHRA); 2018. https://www.gov.uk/drug-safety-update/esmya-ulipristal-acetate-and-risk-of-serious-liver-injury-new-restrictions-to-use-and-requirements-for-liver-function-monitoring-before-during-and-after-treatment

  • Morris H. Surgical pathology of the lower uterine segment caesarean section scar: is the scar a source of clinical symptoms? Int J Gynecol Pathol. 1995;14(1):16–20.

    Article  CAS  PubMed  Google Scholar 

  • Multinu F, Casarin J, Tortorella L, Huang Y, Weaver A, Angioni S, et al. Incidence of sarcoma in patients undergoing hysterectomy for benign indications: a population-based study. Am J Obstet Gynecol. 2019;220(2):179 e1–e10.

    Article  Google Scholar 

  • Munro MG, Critchley HO, Broder MS, Fraser IS (2011), FIGO classification system (PALM–COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011;113:3–13. https://doi.org/10.1016/j.ijgo.2010.11.011

    Article  Google Scholar 

  • Munro MG, Critchley HOD, Fraser IS, Committee FMD. The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions. Int J Gynaecol Obstet. 2018;143(3):393–408.

    Article  PubMed  Google Scholar 

  • NICE. Clinical Guideline 44; Heavy menstrual bleeding: National Institute for Health and Clinical Excellence (NICE); 2007. http://www.nice.org.uk/nicemedia/pdf/CG44FullGuideline.pdf

  • NICE. NG88: heavy menstrual bleeding: assessment and management: National Institute for Health and Clinical Excellence (NICE); 2018. https://www.nice.org.uk/guidance/ng88

  • Pecorelli S, Benedet JL, Creasman WT, Shepherd JH. FIGO staging of gynecologic cancer. 1994–1997 FIGO committee on gynecologic oncology. International Federation of Gynecology and Obstetrics. Int J Gynaecol Obstet. 1999;65(3):243–9.

    Article  CAS  PubMed  Google Scholar 

  • RCOG. National heavy menstrual bleeding audit – final report. London: RCOG; 2014a. https://www.rcog.org.uk/globalassets/documents/guidelines/research%2D%2Daudit/national_hmb_audit_final_report_july_2014.pdf

  • RCOG. Advice for Heavy Menstrual Bleeding (HMB) Services and Commissioners; 2014b. https://www.rcog.org.uk/globalassets/documents/guidelines/research%2D%2Daudit/advice-for-hmb-services-booklet.pdf

  • Reavey JJ, Maybin JA, Critchley HO. Physiology of menstruation. In: Kadir RA, James PD, Lee CA, editors. Inherited bleeding disorders in women. 2nd ed. Hoboken: Wiley Blackwell; 2018. p. 29–44.

    Chapter  Google Scholar 

  • Roberts ME, Aynardi JT, Chu CS. Uterine leiomyosarcoma: a review of the literature and update on management options. Gynecol Oncol. 2018;151(3):562–72.

    Article  PubMed  Google Scholar 

  • Shankar M, Lee CA, Sabin CA, Economides DL, Kadir RA. von Willebrand disease in women with menorrhagia: a systematic review. BJOG. 2004;111(7):734–40.

    Article  PubMed  Google Scholar 

  • Sizzi O, Manganaro L, Rossetti A, Saldari M, Florio G, Loddo A, et al. Assessing the risk of laparoscopic morcellation of occult uterine sarcomas during hysterectomy and myomectomy: literature review and the ISGE recommendations. Eur J Obstet Gynecol Reprod Biol. 2018;220:30–8.

    Article  PubMed  Google Scholar 

  • Speroff L, Fritz MA. Clinical gynecologic endocrinology and fertility. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2005.

    Google Scholar 

  • Stewart EA. Uterine fibroids. Lancet. 2001;357(9252):293–8.

    Article  CAS  PubMed  Google Scholar 

  • Stoffel E, Mukherjee B, Raymond VM, Tayob N, Kastrinos F, Sparr J, et al. Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology. 2009;137(5):1621–7.

    Article  PubMed  Google Scholar 

  • Thomas CC, Wingo PA, Dolan MS, Lee NC, Richardson LC. Endometrial cancer risk among younger, overweight women. Obstet Gynecol. 2009;114(1):22–7.

    Article  PubMed  Google Scholar 

  • Van den Bosch T, Dueholm M, Leone FP, Valentin L, Rasmussen CK, Votino A, et al. Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group. Ultrasound Obstet Gynecol. 2015;46(3):284–98.

    Article  PubMed  Google Scholar 

  • Woolcock JG, Critchley HO, Munro MG, Broder MS, Fraser IS. Review of the confusion in current and historical terminology and definitions for disturbances of menstrual bleeding. Fertil Steril. 2008;90(6):2269–80.

    Article  PubMed  Google Scholar 

  • Zalewski K, Misiek M, Gozdz S, Bidzinski M. The new FIGO staging system for ovarian, fallopian tube and primary peritoneal cancer – 2014 update. Oncol Clin Pract. 2015;11(3):129–34.

    Google Scholar 

Download references

Conflict of Interest

Rohan Chodankar is supported as a Clinical Research Fellow by Bayer AG and has no other conflict of interest. HODC has clinical research support for laboratory consumables and staff from Bayer AG and provides consultancy advice (but with no personal remuneration) for Bayer AG, PregLem SA, Gedeon Richter, Vifor Pharma UK Ltd, AbbVie Inc., Myovant Sciences GmbH. HODC receives royalties from UpToDate for an article on abnormal uterine bleeding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hilary O. D. Critchley .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Chodankar, R.R., Critchley, H.O.D. (2020). Abnormal Uterine Bleeding. In: Petraglia, F., Fauser, B. (eds) Female Reproductive Dysfunction . Endocrinology. Springer, Cham. https://doi.org/10.1007/978-3-030-14782-2_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-14782-2_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-14781-5

  • Online ISBN: 978-3-030-14782-2

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics